PATHOLOGY AND LABORATORY MEDICINE GRAND ROUNDS
Dartmouth Hitchcock Medical Center

“The Significance of Identifying Diverse Growth Patterns In Lung Adenocarcinoma”

Haodong Xu, MD, PhD
Director of Anatomic Pathology
Professor of Pathology
Wake Forest University School of Medicine
 Winston-Salem, NC

Wednesday, February 14, 2024

4:30 PM
DHMC, Auditorium E

Learning Outcome:
Participants will be able to discuss new topics in general pathology and laboratory medicine, as well as molecular pathology and other advanced biomedical technologies.

Target Audience:  Dept. Faculty, Residents, Fellows, and Medical Students.

Description
This presentation will:

1)  Review the growth patterns observed in lung adenocarcinoma.
2)  Investigate the overall clinical outcomes of lung adenocarcinoma across various growth patterns.
3)  Assess the impact of different growth patterns on the subtyping, histologic grading and T-staging of lung adenocarcinoma.
4)  Delve into the molecular signatures associated with classified growth patterns of lung adenocarcinoma. 

Bio
Dr. Haodong Xu holds a tenured position as a Professor and serves as the Director of Anatomic Pathology in the Department of Pathology at Wake Forest University School of Medicine. With expertise in cardiovascular, lung, and H&N pathology, he is also a seasoned diagnostic pathologist. As a dedicated researcher, he focuses on understanding the mechanisms underlying ventricular arrhythmias in ischemic heart disease, with support funding from NIH and AHA. Furthermore, he actively contributes to cancer research by identifying biomarkers, particularly in lung cancer. His editorial contributions extend to journals like Human Pathology and AIMM.

"Dartmouth Health is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.”    

 “Dartmouth Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.”

Haodong Xu, MD, PhD has no financial disclosures.